
The latest people news happenings over the past month.

Collaboration to focus on digital therapeutics.

After concerns raised by multiple supply chain participants over readiness, the agency steps back.

Program designed to aid life science organizations in improving go-to-market strategy.

Expansion allows facility to provide E2E services in one location, including commercial manufacturing.


The deal helps the logistics provider—who operates in the healthcare space—continue to grow its services.

Program’s goal is to maximize aviation industry’s contribution to development across the African continent.

Abrysvo is allowed to be given to individuals who are 32-36 weeks pregnant.

Acquisition expands 3PL’s presence in India, adds 7.7 million square feet of facility space.

In what could presage a radical reshuffling of drug pricing and distribution, the insurer is dropping CVS Caremark as its PBM.

Guidelines expected to assist companies with EPCIS-based sTI/TS data exchange as they prepare to meet November DSCSA deadlines.

The act is currently set to go into effect in just over three months.

H1 Mobile to offer latest information and research in multiple fields.

Analysis requested by PhRMA indicates that these facilities charge anywhere from two to seven times what they originally paid.

The company anticipates that the offering will help maximize life sciences brands’ commercial potential.

Experienced pharma exec joins the business’ management board.

Company will focus on its managed access services.

CDMO makes four new executive appointments.

Citing growth as contributing factor, SaaS provider plans on relocating to a biopharma hub in Waltham, MA.

Strategy includes a layoff of nearly 400 employees.

Karin Van Den Brekel, Niall Walsh hired to manage EMEA and Ireland respectively.

The company will occupy approximately 62,000 square feet of the new building.

The plant— dedicated to cell and gene therapy development—welcomes additional warehouse space, and aims to meet commercial needs.

Stephanie Smith Cooney joins PBM business to further develop partnerships, especially with independent pharmacists in local communities.

Offering provides assistance through the post-approval lifecycle of drugs.

The finished product, company says, can assist with the medical supply chain’s vaccine distribution process.

Latest IATA stats for the month show that it was only 2.4% below pre-pandemic levels.

Company is seeking monetary damages from the alleged violation.